{"transactions":[{"id":892355,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":65606,"kind":"person","name":"Bancroft Robert E.","position":1,"cik":"0002066370","reported_name":"Bancroft Robert E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Class A Common Stock","published_at":"2026-02-20T01:40:27.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted stock units granted on February 17, 2026 (the \"Grant Date\"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units granted on February 17, 2026 (the \"Grant Date\"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date."}],"balance_after":3177103,"source":{"system":"sec-edgar","filing":"0001104659-26-017726","document":"tm266901-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000110465926017726/tm266901-1_4seq1.xml","form_type":"4"}},{"id":1144609,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":65606,"kind":"person","name":"Bancroft Robert E.","position":1,"cik":"0002066370","reported_name":"Bancroft Robert E.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Class A Common Stock","published_at":"2025-05-16T20:17:08.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":177103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Class A Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on each anniversary of April 29, 2025."}],"balance_after":177103,"source":{"system":"sec-edgar","filing":"0001610717-25-000120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000161071725000120/form4.xml","form_type":"4"}},{"id":1162238,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":65606,"kind":"person","name":"Bancroft Robert E.","position":1,"cik":"0002066370","reported_name":"Bancroft Robert E.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2025-05-01T20:50:50.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":59034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on each anniversary measured from April 29, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":59034,"derivative":{"exercise_price":0.41,"expiration_date":"2035-04-29","underlying":"Class A Common Stock","underlying_shares":59034},"source":{"system":"sec-edgar","filing":"0001610717-25-000111","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000161071725000111/form4.xml","form_type":"4"}}]}